Docoh
Loading...

AIM AIM ImmunoTech

969 filings

Page 2 of 49
Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q3
AIM AIM ImmunoTech Inc
14 Nov 21
Quarterly report
7:00pm
8-K
AIM AIM ImmunoTech Inc
7 Oct 21
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
AIM AIM ImmunoTech Inc
6 Oct 21
Regulation FD Disclosure
7:30am
8-K
AIM AIM ImmunoTech Inc
30 Sep 21
Entry into a Material Definitive Agreement
6:11am
8-K
AIM AIM ImmunoTech Inc
21 Sep 21
Departure of Directors or Certain Officers
4:30pm
8-K
AIM AIM ImmunoTech Inc
17 Sep 21
Regulation FD Disclosure
7:30am
DEF 14A
AIM AIM ImmunoTech Inc
17 Aug 21
Definitive proxy
4:30pm
10-Q/A
2021 Q2
AIM AIM ImmunoTech Inc
17 Aug 21
Quarterly report (amended)
4:30pm
10-Q
2021 Q2
AIM AIM ImmunoTech Inc
16 Aug 21
Quarterly report
4:51pm
4
Equels Thomas K.
16 Jul 21
AIM ImmunoTech / THOMAS K. EQUELS ownership change
12:07pm
8-K
AIM AIM ImmunoTech Inc
14 Jul 21
Regulation FD Disclosure
10:30am
8-K
AIM AIM ImmunoTech Inc
13 Jul 21
Entry into a Material Definitive Agreement
8:00am
S-8
AIM AIM ImmunoTech Inc
1 Jul 21
Registration of securities for employees
4:47pm
8-K
AIM AIM ImmunoTech Inc
14 Jun 21
Other Events
7:15am
8-K
AIM AIM ImmunoTech Inc
27 May 21
Announces plans to conduct Phase 1/2 clinical study incorporating new inhalation technology if the preliminary results of the testing are positive
8:45am
8-K
AIM AIM ImmunoTech Inc
18 May 21
Regulation FD Disclosure
7:30am
10-Q
2021 Q1
AIM AIM ImmunoTech Inc
17 May 21
Quarterly report
4:31pm
8-K
AIM AIM ImmunoTech Inc
6 May 21
Other Events
1:45pm
8-K
AIM AIM ImmunoTech Inc
3 May 21
AIM ImmunoTech CEO Thomas K. Equels Participates in Fireside Chat with Ascendiant Capital Markets Analyst Ed Woo
7:30am
8-K
AIM AIM ImmunoTech Inc
23 Apr 21
Completion of Acquisition or Disposition of Assets
4:45pm